BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 16219517)

  • 1. Perinatal outcome of fetus with isolated congenital second degree atrioventricular block without maternal anti-SSA/Ro-SSB/La antibodies.
    Chang YL; Hsieh PC; Chang SD; Chao AS; Liang CC; Soong YK
    Eur J Obstet Gynecol Reprod Biol; 2005 Oct; 122(2):167-71. PubMed ID: 16219517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block.
    Mevorach D; Elchalal U; Rein AJ
    Curr Opin Rheumatol; 2009 Sep; 21(5):478-82. PubMed ID: 19584727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block.
    Tseng CE; Caldwell K; Feit S; Chan EK; Buyon JP
    J Rheumatol; 1996 May; 23(5):925-32. PubMed ID: 8724310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between maternal and neonatal levels of antibodies to 48 kDa SSB(La), 52 kDa SSA(Ro), and 60 kDa SSA(Ro) in pregnancies complicated by congenital heart block.
    Buyon JP; Waltuck J; Caldwell K; Crawford B; Slade SG; Copel J; Chan EK
    J Rheumatol; 1994 Oct; 21(10):1943-50. PubMed ID: 7837164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-SSA/Ro and anti-SSB/La antibodies. What's new?].
    Meyer O
    Ann Med Interne (Paris); 2002 Dec; 153(8):520-9. PubMed ID: 12610426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent fetal sinus bradycardia associated with maternal anti-SSA/Ro and anti-SSB/La antibodies.
    Chockalingam P; Jaeggi ET; Rammeloo LA; Haak MC; Adama van Scheltema PN; Breur JM; Bartelings MM; Clur SA; Blom NA
    J Rheumatol; 2011 Dec; 38(12):2682-5. PubMed ID: 22089457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome and growth of infants fetally exposed to heart block-associated maternal anti-Ro52/SSA autoantibodies.
    Skog A; Wahren-Herlenius M; Sundström B; Bremme K; Sonesson SE
    Pediatrics; 2008 Apr; 121(4):e803-9. PubMed ID: 18381509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of infants from mothers with anti-SSA/Ro antibodies.
    Motta M; Rodriguez-Perez C; Tincani A; Lojacono A; Chirico G
    J Perinatol; 2007 May; 27(5):278-83. PubMed ID: 17363909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases--a multicentre prospective study.
    Gerosa M; Cimaz R; Stramba-Badiale M; Goulene K; Meregalli E; Trespidi L; Acaia B; Cattaneo R; Tincani A; Motta M; Doria A; Zulian F; Milanesi O; Brucato A; Riboldi P; Meroni PL
    Rheumatology (Oxford); 2007 Aug; 46(8):1285-9. PubMed ID: 17449486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.
    Martínez-Sánchez N; Pérez-Pinto S; Robles-Marhuenda Á; Arnalich-Fernández F; Martín Cameán M; Hueso Zalvide E; Bartha JL
    Immunol Res; 2017 Apr; 65(2):487-494. PubMed ID: 28138914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More to death than dying: apoptosis in the pathogenesis of SSA/Ro-SSB/La-associated congenital heart block.
    Clancy RM; Buyon JP
    Rheum Dis Clin North Am; 2004 Aug; 30(3):589-602, x. PubMed ID: 15261343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune response in mothers of children with congenital and postnatally diagnosed isolated heart block: a population based study.
    Julkunen H; Miettinen A; Walle TK; Chan EK; Eronen M
    J Rheumatol; 2004 Jan; 31(1):183-9. PubMed ID: 14705240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Ro (SSA) and anti-La (SSB) antibodies and complete congenital heart block.
    Finkelstein Y; Adler Y; Harel L; Nussinovitch M; Youinou P
    Ann Med Interne (Paris); 1997; 148(3):205-8. PubMed ID: 9255327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of heart block in children of SSA/SSB-autoantibody-positive women is associated with maternal age and displays a season-of-birth pattern.
    Ambrosi A; Salomonsson S; Eliasson H; Zeffer E; Skog A; Dzikaite V; Bergman G; Fernlund E; Tingström J; Theander E; Rydberg A; Skogh T; Öhman A; Lundström U; Mellander M; Winqvist O; Fored M; Ekbom A; Alfredsson L; Källberg H; Olsson T; Gadler F; Jonzon A; Kockum I; Sonesson SE; Wahren-Herlenius M
    Ann Rheum Dis; 2012 Mar; 71(3):334-40. PubMed ID: 21953338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA/Ro-SSB/La antibodies: a prospective, observational, fetal kinetocardiogram-based study.
    Rein AJ; Mevorach D; Perles Z; Gavri S; Nadjari M; Nir A; Elchalal U
    Circulation; 2009 Apr; 119(14):1867-72. PubMed ID: 19332471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of mothers of children with complete congenital heart block.
    Press J; Uziel Y; Laxer RM; Luy L; Hamilton RM; Silverman ED
    Am J Med; 1996 Mar; 100(3):328-32. PubMed ID: 8629679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study.
    Friedman DM; Kim MY; Copel JA; Davis C; Phoon CK; Glickstein JS; Buyon JP;
    Circulation; 2008 Jan; 117(4):485-93. PubMed ID: 18195175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Congenital complete atrioventricular block in children: pathogenesis and clinical outcomes].
    Udink ten Cate FE; Breur JM; van Woerkom JM; Kruize AA; Stoutenbeek P; Meijboom EJ
    Ned Tijdschr Geneeskd; 2002 Sep; 146(38):1777-81. PubMed ID: 12369438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary Sjögren's syndrome--treatment of fetal incomplete atrioventricular block with dexamethasone.
    Theander E; Brucato A; Gudmundsson S; Salomonsson S; Wahren-Herlenius M; Manthorpe R
    J Rheumatol; 2001 Feb; 28(2):373-6. PubMed ID: 11246681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolongation of the atrioventricular conduction in fetuses exposed to maternal anti-Ro/SSA and anti-La/SSB antibodies did not predict progressive heart block. A prospective observational study on the effects of maternal antibodies on 165 fetuses.
    Jaeggi ET; Silverman ED; Laskin C; Kingdom J; Golding F; Weber R
    J Am Coll Cardiol; 2011 Mar; 57(13):1487-92. PubMed ID: 21435519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.